Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients: a Randomized, Double-blind, Placebo-controlled Trial

NCT05395143 is registered in ClinicalTrials.gov with Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh as lead sponsor.

NCT NCT05395143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05395143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients: a Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase
Phase 2
Overall status
Unknown status
Start date
May 1, 2021
Completion date
July 10, 2022
Enrollment
92 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemias